Literature DB >> 20484887

Oxidative stress in benign prostatic hyperplasia and prostate cancer.

Gianna Pace1, Caterina Di Massimo, Daniela De Amicis, Carlo Corbacelli, Laura Di Renzo, Carlo Vicentini, Lucio Miano, Maria Giuliana Tozzi Ciancarelli.   

Abstract

OBJECTIVE: The aim was to verify whether oxidative stress could represent a common key factor of benign prostatic hyperplasia (BPH) and prostate cancer (PCa). SUBJECTS AND METHODS: 15 patients affected by BPH, 15 with PCa and 15 controls were enrolled. Blood samples were withdrawn systemically and locally during radical retropubic prostatectomy in patients with PCa and during transvesical retropubic adenomectomy in patients diagnosed with BPH. Plasma oxidized low-density lipoprotein, peroxides, and total equivalent antioxidant capacity (TEAC) including plasma superoxide dismutase (SOD) determination were analyzed as oxidative markers.
RESULTS: With respect to the control group, high plasma peroxides and decreased TEAC levels were measured in patients affected by both PCa and BPH. Plasma peroxides were significantly higher in patients with PCa with respect to BPH. A positive correlation was found between peroxides and TEAC values in samples withdrawn locally in patients affected by PCa. An inverse correlation between peroxides and TEAC was observed in patients with BPH. No statistically significant modifications were observed as concerns SOD activity and LDL oxidability.
CONCLUSIONS: Our findings confirm a significant unbalance of redox status in patients affected by BPH and PCa, and suggest a potential involvement of oxidative stress as a determinant in the pathogenesis of these diseases.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484887     DOI: 10.1159/000315064

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  20 in total

1.  Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.

Authors:  D Altavilla; L Minutoli; F Polito; N Irrera; S Arena; C Magno; M Rinaldi; B P Burnett; F Squadrito; A Bitto
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.

Authors:  Jing Chen; Huai-Fen Zhang; Chao-Mei Xiong; Jin-Lan Ruan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

3.  Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).

Authors:  Irene Paterniti; Michela Campolo; Marika Cordaro; Rosalba Siracusa; Antonio Filippone; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Inflamm Res       Date:  2018-04-20       Impact factor: 4.575

4.  Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production.

Authors:  Yu Zeng; Dong Gao; John J Kim; Takumi Shiraishi; Naoki Terada; Yoshiyuki Kakehi; Chuize Kong; Robert H Getzenberg; Prakash Kulkarni
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

5.  Evaluation of the Therapeutic Effect of the Traditional Herbal Medicine Atrifil and Oshagh Gum on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats.

Authors:  Fatemeh Akbari; Mohammad Azadbakht; Anand Gaurav; Fatemeh Azimi; Zahra Mahdizadeh; Lale Vahedi; Ayob Barzegar Nejad; Aroona Chabra; Mohammad Eghbali
Journal:  Adv Urol       Date:  2022-07-05

Review 6.  The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.

Authors:  Xun Fu; Huan Liu; Jiang Liu; Michael E DiSanto; Xinhua Zhang
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

7.  Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study.

Authors:  Terrence M Vance; Ying Wang; L Joseph Su; Elizabeth T H Fontham; Susan E Steck; Lenore Arab; Jeannette T Bensen; James L Mohler; Ming-Hui Chen; Ock K Chun
Journal:  Nutr Cancer       Date:  2016-02-04       Impact factor: 2.900

8.  Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients.

Authors:  Funda Kosova; Gökhan Temeltaş; Zeki Arı; Murat Lekili
Journal:  Tumour Biol       Date:  2013-12-28

9.  Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population.

Authors:  Hosik Seok; Su Kang Kim; Koo Han Yoo; Byung-Cheol Lee; Young Ock Kim; Joo-Ho Chung
Journal:  J Exerc Rehabil       Date:  2014-12-31

Review 10.  High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.

Authors:  Aida Barreiro-Alonso; Mónica Lamas-Maceiras; Esther Rodríguez-Belmonte; Ángel Vizoso-Vázquez; María Quindós; M Esperanza Cerdán
Journal:  Oxid Med Cell Longev       Date:  2015-11-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.